Performance analysis of KING PHARMACEUTICALS (KG)
Annual Return
Over the past 3 years, KG has had an average annual return of -94.78%, underperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, KG has had an average annual return of -94.78%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, KG has had an average annual return of -94.78%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Feb 28, 2011, KG has had an average annual return of -19.76%, underperforming the benchmark SPY, which returned +13.87% annual.
| 2026 | 2025 | 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.39% | -96.40% | +0% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +15.83% | +29.50% | -29.81% | -10.03% | +15.84% | -20.00% | +6.65% | -6.39% | |||||
| 2025 | -91.08% | +4.37% | +2.47% | -0.84% | +1.37% | -27.32% | -24.96% | -31.17% | -96.40% |
Drawdown analysis of KING PHARMACEUTICALS (KG)
The maximum drawdown for the KG was -97.02%, occurring on Jan 7, 2026. This drawdown has not yet recovered.
The current KG drawdown is -96.63%.
Since Feb 28, 2011 KG has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.02% | Feb 28, 2011 | 161 | Jan 7, 2026 | Ongoing | Ongoing | Ongoing |